Position in GTBP
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$5,341
+$894 QoQ
Shares Held
10,900
0.0% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 16 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GTBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PARSONS CAPITAL MANAGEMENT INC/RI holds $8,774,262 across 6 Biotechnology names. GTBP ranks #6 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,779 | $4,857,522 | |
| 2 | RLMD |
Relmada Therapeutics, Inc.
|
354,069 | $2,450,157 | |
| 3 | NRXS |
Neuraxis, INC
|
117,808 | $861,176 | |
| 4 | TECH |
BIO-TECHNE Corp
|
6,712 | $474,202 | |
| 5 | MDXG |
Mimedx Group, Inc.
|
32,692 | $125,864 | |
| 6 | GTBP |
GT Biopharma, Inc.
This page
|
10,900 | $5,341 |
All Filings in GTBP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,341 | 10,900 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $4,447 | 10,900 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $8,556 | 10,900 | Shares | Sole | 2026-01-13 | |
| No filing history on record for this holder in this stock. | ||||||